Following is a summary of current health news briefs. Bristol Myers' lung disease drug succeeds at lower dose in late-stage trial Bristol Myers Squibb said on Monday a lower dose of its experimental
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)